Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

Comparison of Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation of G-CSF-Stimulated Bone Marrow Versus Non-Stimulated Bone Marrow Versus Peripheral Blood

Ilana Schlam, MD, Samantha Buszek*, MD, Matan R Rothschild, MD, Miguel Islas-Ohlmayer, MD, James Essell

Blood (2017) 130 (Supplement 1): 5493.

https://doi.org/10.1182/blood.V130.Suppl_1.5493.5493

Published: 2017

Journal Articles

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Shinsuke Takagi, MD PhD, Mitsuhiro Yuasa, MD, Naoyuki Uchida, MD PhD, Kyosuke Yamaguchi, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Atsushi Wake, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Koji Izutsu, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2016) 128 (22): 5747.

https://doi.org/10.1182/blood.V128.22.5747.5747

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases

Hiroki Mizumaki, MD, Shinsuke Takagi, MD PhD, Naoyuki Uchida, MD PhD, Sachie Wada, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Aya Nishida, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Koji Izutsu, Shuichi Taniguchi, MD PhD

Blood (2014) 124 (21): 5931.

https://doi.org/10.1182/blood.V124.21.5931.5931

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Shinsuke Takagi, MD PhD, Kazuhiro Masuoka, Naoyuki Uchida, MD PhD, Mineo Kurokawa, MD PhD, Hirohisa Nakamae, Mitsuru Tsudo, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Akiyoshi Takami

Blood (2014) 124 (21): 2547.

https://doi.org/10.1182/blood.V124.21.2547.2547

Published: 2014

Journal Articles

Comparable 2-Year-Overall and Progression Free Survival Among Unrelated Cord Blood Transplantation, Unrelated Bone Marrow Transplantation, and Related Peripheral Blood Stem Cell Transplantation In Adult Patients With Standard-Risk Hematological Diseases; A Single Center Retrospective Analysis

Aya Nishida, Daisuke Kaji, MD, Hikari Ota, MD, Kazuya Ishiwata, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Shinsuke Takagi, Yuki Asano-Mori, Go Yamamoto, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Shigeyoshi Makino, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2013) 122 (21): 3400.

https://doi.org/10.1182/blood.V122.21.3400.3400

Published: 2013

Journal Articles

Clinicopathological Study Of 12 Cases Of EBV-Associated Post-Transplant Lymphoproliferative Disorder (PTLD) After Allogeneic SCT: A Single Institution Analysis Of 825 Transplants Including 572 Cord Blood Transplants In Toranomon Hospital

Daisuke Kaji, MD, Yasunori Ota, MD, PhD, Aya Nishida, MD, Hisashi Yamamoto, MD, Hikari Ota, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Go Yamamoto, MD, PhD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Atsushi Wake, MD, PhD, Koji Izutsu, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2013) 122 (21): 3323.

https://doi.org/10.1182/blood.V122.21.3323.3323

Published: 2013

Journal Articles

Clinical Significance of Addition of Cytarabine or Thiotepa to TBI/CY Regimen.

Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Maki Hagihara, MD, Rika Ohshima, MD, Etsuko Yamazaki, MD, Hideyuki Koharazawa, MD, Jun Taguchi, MD, Naoto Tomita, MD, Katsumichi Fujimaki, MD, Rika Sakai, MD, Hiroyuki Fujita, Shin Fujisawa, MD, Atsuo Maruta, MD, Yoshiaki Ishigatsubo, MD, Heiwa Kanamori, MD, PhD

Blood (2012) 120 (21): 3028.

https://doi.org/10.1182/blood.V120.21.3028.3028

Published: 2012

Journal Articles

Unfavorable Outcome of Single-Unit Umbilical Cord Blood Transplantation for Elderly Patients with Myelodysplastic Syndromes.

Kazunari Aoki, MD, Ken Ishiyama, MD, PhD, Hidehiro Itonaga, MD, Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Yasunori Ueda, MD, PhD, Noriko Doki, MD, Yasuhiro Sugio, MD, Yasuo Morishima, MD, Tokiko Nagamura, MD, PhD, Junji Tanaka, M.D., Yoshiko Atsuta, MD, PhD, Takayuki Ishikawa, M.D., Ph.D., Yasushi Miyazaki, MD, PhD

Blood (2012) 120 (21): 3118.

https://doi.org/10.1182/blood.V120.21.3118.3118

Published: 2012

Journal Articles

Extremely Higher Incidence of CMV-pp65 Antigenemia After Allogeneic Hematopoietic Stem Cell Transplantation in Adult T-Cell Leukemia/Lymphoma (ATL) Compared with Other Hematological Diseases

Nobuaki Nakano, M.D., Yoshifusa Takatsuka, M.D., Shogo Takeuchi, M.D., Masahito Tokunaga, M.D., Ayumu Kubota, M.D., Mayumi Tokunaga, M.D., Torahiko Makino, M.D., Atae Utsunomiya, MD, PhD

Blood (2012) 120 (21): 4477.

https://doi.org/10.1182/blood.V120.21.4477.4477

Published: 2012

Journal Articles

Higher HHV-6 Reactivation After Cord Blood Allo-SCT Is Not Related to HHV-6 Cell Receptor CD46 Expression

Patrice Chevallier, MD, Nelly Robillard, Marina Illiaquer, Julie Esbelin, Mohamad Mohty, MD PhD, Celine Bodin-Bressollette, Thierry Guillaume, MD, Veronique Stocco, MD, Fabienne Auffray, Sophie Derenne, Lucie Planche, Marie-christine Béné, Berthe-Marie Imbert-Marcille

Blood (2012) 120 (21): 1931.

https://doi.org/10.1182/blood.V120.21.1931.1931

Published: 2012

Journal Articles

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Minauchi Koichiro, MD, Akio Shigematsu, MD, PhD, Masanobu Nakata, MD, Toshihiro Matsukawa, MD, Koh Ebata, MD, Tomohiro Yamakawa, MD, Tomoyuki Saga, MD, Kanako Shima, MD, Makoto Ibata, MD, PhD, Junichi Sugita, MD, PhD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Masahiro Ogasawara, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Imamura, MD, PhD, Naoki Kobayashi, MD, Ph.D

Blood (2011) 118 (21): 4154.

https://doi.org/10.1182/blood.V118.21.4154.4154

Published: 2011

Journal Articles

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Naoyuki Uchida, MD, Michihiro Hidaka, MD, Toru Sakura, MD, Toshihiro Miyamoto, MD, PhD, Tomoaki Fujisaki, MD, PhD, Tetsuya Eto, MD, PhD, Yoshinobu Maeda, MD, PhD, Kenji Fukuno, MD, PhD, Kana Matsumoto, PhD, Kunihiko Morita, PhD, Junji Kishimoto, PhD, Takahiro Fukuda, MD, PhD, Takanori Teshima, MD, PhD, Shuichi Taniguchi, MD, PhD, Shin-Ichiro Mori, MD, Mine Harada, MD, PhD

Blood (2010) 116 (21): 3477.

https://doi.org/10.1182/blood.V116.21.3477.3477

Published: 2010

Journal Articles

Outocomes of Second Unrelated Cord Blood Transplant for Relapse After First Allogeneic Transplant In Adult Patients with Progressive Acute Myeloid Leukimia/Myelodysplastic Syndrome.

Sachi Tainosho, MD, PhD, Kazuhiro Masuoka, MD, PhD, Aya Nishida, MD, Nobuaki Nakano, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Yuki Asano-Mori, MD, PhD, Naoyuki Uchida, MD, PhD, Koji Izutsu, MD, PhD, Atsushi Wake, MD, PhD, Shigeyoshi Makino, MD, PhD, Akiko Yoneyama, MD, PhD, Shuichi Taniguchi, MD, PhD

Blood (2010) 116 (21): 1295.

https://doi.org/10.1182/blood.V116.21.1295.1295

Published: 2010

Journal Articles

Chimerism Kinetics of Unfractionated Bone Marrow In the First Year After Allogeneic Hematopoietic Cell Transplantation Is Predictive of Relapse In Patients with AML and MDS.

Apostolia Papalexandri, Chryssa Apostolou, Georgia Voutiadou, Tasoula Touloumenidou, Ioannis Zorbas, Ioannis Batsis, Christos Smias, Evangelia Stalika, Angeliki Paleta, Ioanna Sakellari, Achilles Anagnostopoulos

Blood (2010) 116 (21): 1297.

https://doi.org/10.1182/blood.V116.21.1297.1297

Published: 2010

Journal Articles

Comparative Single Institute Analysis of Cord Blood Transplantation From Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Adult Patients with Acute Myeloid Leukemia / Myelodysplastic Syndrome.

Kazuhiro Masuoka, Kazuya Ishiwata, Masanori Tsuji, Shinsuke Takagi, Hisashi Yamamoto, Yuki Mori, Naofumi Matsuno, Naoyuki Uchida, Atsushi Wake, Shigeyoshi Makino, Akiko Yoneyama, Shuichi Taniguchi

Blood (2009) 114 (22): 3382.

https://doi.org/10.1182/blood.V114.22.3382.3382

Published: 2009

Journal Articles

Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen.

Naoyuki Uchida, MD, Atsushi Wake, MD, Kazuhiro Masuoka, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Shinsuke Takagi, MD, Daisuke Kato, MD, Sachiko Seo, MD, Naofumi Matsuno, MD, Shigesaburo Miyakoshi, MD, Akiko Yoneyama, MD, Shuichi Taniguchi, MD

Blood (2007) 110 (11): 2011.

https://doi.org/10.1182/blood.V110.11.2011.2011

Published: 2007

Journal Articles

Clinical Feature and Prognosis of 60 Patients Presenting Graft Failure (GF) after Allogeneic Stem Cell Transplantation (SCT).

Maki Hagihara, Heiwa Kanamori, Fumiaki Yoshiba, Nobuyuki Aotsuka, Masatsugu Tanaka, Takehiko Mori, Chiaki Nakaseko, Shin Fujisawa, Tohru Sakura, Taeko Uehara, Nobutaka Kawai, Takafumi Matsushima, Shinichiro Machida, Hisashi Makita, Atsuo Maruta, Hisashi Sakamaki

Blood (2007) 110 (11): 4929.

https://doi.org/10.1182/blood.V110.11.4929.4929

Published: 2007

Journal Articles

Bloodstream Infection after Reduced-Intensity Umbilical Cord Blood Transplantation Versus Other Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Shinsuke Takagi, MD, Kazuya Ishiwata, MD, Masanori Tsuji, MD, Hisashi Yamamoto, MD, Daisuke Kato, MD, Yoshiko Matsuhashi, MD, Eiji Kusumi, MD, Sachiko Seo, MD, Naofumi Matsuno, MD, Tomoko Matsumura, MD, Naoyuki Uchida, MD, Kazuhiro Masuoka, MD, Atsushi Wake, MD, Shigesaburo Miyakoshi, MD, Akiko Yoneyama, MD, Michio Matsuzaki, MD, Shuichi Taniguchi, MD

Blood (2007) 110 (11): 4981.

https://doi.org/10.1182/blood.V110.11.4981.4981

Published: 2007

NARROW

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Comparison of Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation of G-CSF-Stimulated Bone Marrow Versus Non-Stimulated Bone Marrow Versus Peripheral Blood

Possible Therapeutic Potential of Recombinant Human Soluble Thrombomoduline Alpha for the Treatment of SOS/VOD: A Retrospective Study in Toranomon Hospital

Allogeneic Hematopoietic Cell Transplantation Is a Curative Treatment Option for Advanced-Stage Chronic Myeloid Leukemia in the TKI Era, a Single Institution Retrospective Study of 29 Post AP/BC Cases

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Comparable 2-Year-Overall and Progression Free Survival Among Unrelated Cord Blood Transplantation, Unrelated Bone Marrow Transplantation, and Related Peripheral Blood Stem Cell Transplantation In Adult Patients With Standard-Risk Hematological Diseases; A Single Center Retrospective Analysis

Clinicopathological Study Of 12 Cases Of EBV-Associated Post-Transplant Lymphoproliferative Disorder (PTLD) After Allogeneic SCT: A Single Institution Analysis Of 825 Transplants Including 572 Cord Blood Transplants In Toranomon Hospital

Clinical Significance of Addition of Cytarabine or Thiotepa to TBI/CY Regimen.

Unfavorable Outcome of Single-Unit Umbilical Cord Blood Transplantation for Elderly Patients with Myelodysplastic Syndromes.

Extremely Higher Incidence of CMV-pp65 Antigenemia After Allogeneic Hematopoietic Stem Cell Transplantation in Adult T-Cell Leukemia/Lymphoma (ATL) Compared with Other Hematological Diseases

Higher HHV-6 Reactivation After Cord Blood Allo-SCT Is Not Related to HHV-6 Cell Receptor CD46 Expression

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Outocomes of Second Unrelated Cord Blood Transplant for Relapse After First Allogeneic Transplant In Adult Patients with Progressive Acute Myeloid Leukimia/Myelodysplastic Syndrome.

Chimerism Kinetics of Unfractionated Bone Marrow In the First Year After Allogeneic Hematopoietic Cell Transplantation Is Predictive of Relapse In Patients with AML and MDS.

Comparative Single Institute Analysis of Cord Blood Transplantation From Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Adult Patients with Acute Myeloid Leukemia / Myelodysplastic Syndrome.

Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen.

Clinical Feature and Prognosis of 60 Patients Presenting Graft Failure (GF) after Allogeneic Stem Cell Transplantation (SCT).

Bloodstream Infection after Reduced-Intensity Umbilical Cord Blood Transplantation Versus Other Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only